Yasen Yimit
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yasen Yimit has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Hui Dong
Department of Pathology Eastern Hepatobiliary Surgery Hospital The Third Affiliated Hospital of Naval Medical University Shanghai China
1 shared publication Jie Yuan
Department of Radiology Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine Shanghai China
1 shared publicationLinhao Qu
Department of Biomedical Informatics Harvard Medical School Boston Massachusetts USA
1 shared publicationNingyang Jia
Department of Radiology Eastern Hepatobiliary Surgery Hospital The Third Affiliated Hospital of Naval Medical University Shanghai China
1 shared publicationPeijun Wang
Department of Radiology School of Medicine Tongji Hospital Tongji University Shanghai China
1 shared publication- Shihang Wang
Faculty of Applied Sciences, Macao Polytechnic University, Macao 999078, China
1 shared publication
Latest Publications
- Open Access
- 18 October 2026
- Published by Wiley in Advanced Science
Foundation Model‐Enabled Pathology‐Informed MRI Model for Preoperative Prediction of Vessels Encapsulating Tumor Clusters in Resectable Hepatocellular Carcinoma: A Multicenter Retrospective Study
Vessels encapsulating tumor clusters (VETC) are an aggressive vascular phenotype of hepatocellular carcinoma that is usually determined after surgery. A foundation model‐enabled framework for pathology‐informed VETC prediction on pretreatment magnetic resonance imaging (MRI), termed PIVOT, uses paired preoperative multiparametric MRI, postoperative hematoxylin and eosin whole‐slide images, and CD34 immunohistochemistry during model development, while inference requires only preoperative MRI. PIVOT‐MRI uses morphologic and vascular embedding alignment, and PIVOT‐Clinical combines the PIVOT‐MRI score with tumor size and alpha‐fetoprotein. The multicenter retrospective study includes 2052 patients in a training cohort, an internal test cohort, and four external validation cohorts. PIVOT‐MRI achieves an area under the receiver operating characteristic curve of 0.887 in the internal test cohort and 0.839‐0.861 across external cohorts. PIVOT‐Clinical increases the internal‐test area under the curve to 0.904 and PIVOT‐Clinical‐defined groups are associated with different two‐year recurrence risks. Removing both histopathologic alignment branches results in the largest ablation‐related performance decrease. Exploratory radiotranscriptomic analyses showed that higher PIVOT‐MRI scores were associated with angiogenesis‐related, endothelial, and proliferative transcriptional programs. PIVOT enables noninvasive preoperative assessment of pathology‐defined vascular aggressiveness in resectable hepatocellular carcinoma while preserving an MRI‐only clinical inference pathway.
- 18 October 2026
- Published by Wiley in Advanced Science
Open AccessFoundation Model‐Enabled Pathology‐Informed MRI Model for Preoperative Prediction of Vessels Encapsulating Tumor Clusters in Resectable Hepatocellular Carcinoma: A Multicenter Retrospective Study
Vessels encapsulating tumor clusters (VETC) are an aggressive vascular phenotype of hepatocellular carcinoma that is usually determined after surgery. A foundation model‐enabled framework for pathology‐informed VETC prediction on pretreatment magnetic resonance imaging (MRI), termed PIVOT, uses paired preoperative multiparametric MRI, postoperative hematoxylin and eosin whole‐slide images, and CD34 immunohistochemistry during model development, while inference requires only preoperative MRI. PIVOT‐MRI uses morphologic and vascular embedding alignment, and PIVOT‐Clinical combines the PIVOT‐MRI score with tumor size and alpha‐fetoprotein. The multicenter retrospective study includes 2052 patients in a training cohort, an internal test cohort, and four external validation cohorts. PIVOT‐MRI achieves an area under the receiver operating characteristic curve of 0.887 in the internal test cohort and 0.839‐0.861 across external cohorts. PIVOT‐Clinical increases the internal‐test area under the curve to 0.904 and PIVOT‐Clinical‐defined groups are associated with different two‐year recurrence risks. Removing both histopathologic alignment branches results in the largest ablation‐related performance decrease. Exploratory radiotranscriptomic analyses showed that higher PIVOT‐MRI scores were associated with angiogenesis‐related, endothelial, and proliferative transcriptional programs. PIVOT enables noninvasive preoperative assessment of pathology‐defined vascular aggressiveness in resectable hepatocellular carcinoma while preserving an MRI‐only clinical inference pathway.